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INTRODUCTION 
Medicinal plants have been used for 
many years for the treatment of human 
diseases
1
 and a number of herbal medicines 
have been developed into therapeutic 
agents or have had promising results.
2-5
 
Plants have the ability to synthesize a wide 
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ABSTRACT 
Background and aims: Human adenoviruses can cause a diversity of clinical diseases, but there is 
no antiviral therapy formally approved by adenovirus infections. Thus, antiviral agents derived 
from medicinal plants which are effective against adenoviruses infections are urgently required. 
Therefore, this research was aimed to evaluate in vitro anti-adenovirus activity of pomegranate 
(Punicagranatum L.) peel extract. 
Methods: In this research, crude ethanol extract of pomegranate peel was prepared.  
Anti-adenovirus activity of the extract was evaluated on Helacell line using MTT  
(3-[4,5-dimethylthiazol–2-yl]-2,5-diphenyltetrazolium bromide) assay. The 50% inhibitory 
concentration (IC50) and 50% Cytotoxicity Concentration (CC50) of the extract were determined 
using regression analysis. To determine antioxidant activity, total phenol content, and flavonoids 
content of the extract, the 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay; Folin-Ciocalteu method 
and aluminum chloride colorimetric method was used, respectively. 
Results: The CC50 and IC50 of the extract were 165±10.1 and 18.6±6.7µg/ml, respectively. The 
selectivity index (SI), the ratio of CC50 and IC50, was 8.89. The IC50 of DPPH radical was 
7.7±1.21 μg/ml, compared to Butylated hydroxytoluene (BHT), with IC50 of 25.41±1.89 μg/ml. 
The total phenol and Flavonoid contents were 282.9 mgGAE/g and 136.6mg/g, respectively. 
Conclusion: Peel extract exhibited anti-adenovirus activity, with SI value of 8.9, suggesting its 
potential use as anti-adenovirus agents. Also, this extract with high phytoconstituents could be a 
promising source of medicinally important natural compound. 
 
Keywords: Antioxidant activity, Antiviral activity, Punicagranatum L., Pomegranate peel, Antiadenovirus. 
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array of compounds and have long been 
used as remedies, and many are now being 
collected and examined in an attempt to 
identify possible sources of drugs.
6-8
 
Incidence of toxic side effects, 
development of resistance, and sensitivity 
of individuals are several reasons for the 
need to substitute these synthetic drugs 
with new ones.
9
 The compounds with 
natural origin, especially herbal medicines, 
have been shown to be reliable source for 
new drugs.
10-12
 
Pomegranate (Punicagranatum L., 
Family Punicaceae) is a popular edible fruit 
which is widely used in traditional 
medicine.
13-15
 Several lines of evidence 
have indicated the therapeutic efficacy of 
pomegranate against different types of 
disorders.
14,16-18
 Pomegranate has also been 
shown to have antimicrobial, antioxidant,
19
 
and anti-inflammatory
20
 properties and to 
decrease the blood pressure.
21
 The 
pomegranate has considerable amounts of 
biologically active phytochemicals 
including flavonoids (e.g. anthocyanins, 
catechins, quercetin, and rutin), other types 
of polyphenols, ellagitannins, and 
antioxidant vitamins.
22,23
 It has been shown 
that plants flushed of flavones, tannin
24-26
 
and alkaloid have antiviral, antibacterial, 
antifungal and antiparasite effects.
27
 
Human adenoviruses (HAdVs) are 
classified in the genus Mastadenovirus, 
which contains seven known HAdV species 
HAdV-A to HAdV-G.
28
 Adenoviruses can 
cause an array of clinical diseases, 
including conjunctivitis, gastroenteritis, 
hepatitis, myocarditis, and pneumonia. 
Most of these occur in children younger 
than the age of 5 years and are generally 
self-limiting illnesses. However, severe and 
life-treating adenovirus infections have 
been reported in some patients, including 
immunocompromised patients.
29,30 
Although, some antiviral drugs are reported 
to inhibit adenovirus infection in vitro and 
used for empirical therapy in severe 
adenovirus infections, such as nucleoside 
analogues and even protease inhibitors, 
usefulness of them had not been 
approved.
30
 Therefore, antiviral agents 
from medicinal plants with new effective 
compounds exhibiting different modes of 
action against Adenoviruses infections are 
urgently needed. 
Iran is endowed with rich and diverse 
local health tradition, which is equally 
matched with rich and diverse plant genetic 
source. A detailed investigation and 
documentation of plants used in local 
health traditions and ethno pharmacological 
evaluation to verify their efficacy and 
safety can lead to the development of 
invaluable herbal drugs or isolation of 
compounds of therapeutic value. Therefore, 
this research was aimed to evaluate in vitro 
Anti-adenoviruses activity of Pomegranate 
(Punicagranatum L.) peel extract and the 
investigation of antioxidant properties of 
this plant material. 
 
METHODS 
Pomegranates were purchased from a 
local market. Peels were first prepared and 
dried for a week at room temperature (RT) 
in darkness. Then the dried peels were 
separately ground to obtain uniform 
powders. The peel powder (100 g) was 
dissolved in 70% ethylealcohole (400ml) 
and kept at RT for 96 h. Subsequently, the 
mixture was filtered and concentrated under 
nearly vacuum pressure and at 40
°
C using 
rotary evaporator. The extracts were kept in 
sterile bottles under refrigerated conditions 
until further use.  The extracts were 
suspended at 37°C in dimethylsulphoxide 
(DMSO) to give a stock solution of 
25mg/mL, dissolved in culture medium, 
filtered (Millipore® 0.22 μm) and stored 
(4°C) until use. The remaining DMSO in 
the wells (maximal 0.2%) did not affect the 
experiment results.
31
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The free-radical scavenging activity 
was measured by the 2,2 diphenyl-1-
picrylhydrazyl (DPPH) method described 
by  Moon and Terao, with some 
modification.
32
 Different amounts of the 
extract and methanol were added to a 
solution of 0.3 mg/mL methanolic solution 
of DPPH to make up a total volume of 3.0 
mL. After standing for 15 min at room 
temperature, the absorbance was measured 
at 517 nm using UV–Vis spectrophotometer 
(UNICO 2100: USA). High absorbance of 
the reaction mixture indicated low free 
radical scavenging activity. Butylated 
hydroxytoluene (BHT) was used as positive 
control. Inhibition of free radical by DPPH 
was calculated as follows: Antiradical activity 
(%)= (Acontrol – Asample) / Acontrol×100. 
The IC50 value defined as the amount of 
antioxidant necessary to decrease the initial 
DPPH concentration by 50% and was 
calculated based on linear regression of plots 
of the percentage antiradical activity against 
the concentration of the tested compounds.
33
 
The experiment was carried out in triplicate 
and the results are average values. 
The total phenolic content of the 
Pomegranate peel extract was determined 
using Folin-Ciocalteu method.
34
 Briefly, 
0.1 ml of the diluted sample was added to 
0.5 ml of 10% (v/v) Folin–Ciocalteu 
reagent and kept at room temperature (RT) 
for 3-8 min. Subsequently, 0.4 ml of 7.5% 
(w/v) sodium carbonate solution was added 
to the mixture. After being kept in total 
darkness for 30 min, the absorbance of the 
reaction mixture was measured at 765 nm 
using a UV–Vis spectrophotometer (UNICO 
2100: USA). Amounts of total phenolic were 
calculated using a gallic acid calibration curve. 
The results were expressed as gallic acid 
equivalents (GAE) g/g of dry plant matter. 
The total flavonoid content of the 
extract was measured as previously 
reported method.
35
 Briefly; 0.5 ml of 
diluted plant material was independently 
mixed with 1.5 ml of methanol, 0.1 ml of 
10% (w/v) aluminum chloride, 0.1 ml of 1 
M potassium acetate, and 2.8 ml of distilled 
water. Following incubation at room 
temperature (RT) for 40 min, the 
absorbance of the reaction mixture was 
read at 415 nm using a UV–Vis 
spectrophotometer (UNICO 2100: USA). 
The results were expressed in mg of routine 
equivalents of dry plant matter by 
comparison with the standard curve, which 
was made in the same condition. 
Hela (cervix adenocarcinoma) cells 
was kindly provided by Pasteure Institute 
of Iran. The cells were grown in Dulbecco's 
Modified Eagle's Medium (DMEM; Gibco, 
USA) supplemented with 10% of fetal 
bovine serum (FBS; Gibco, USA), 100 
µg/mL of streptomycin, 100 UI/ml of 
penicillin and 0.25 µg/mL amphotericin B 
(Gibco, USA), at 37°C and 5% CO2. The 
same medium containing 2% PBS was used 
for cytotoxicity and antiviral assays. 
Adenovirus (type 5) was kindly provided 
by Health Faculty, Tehran University of 
medical sciences, Tehran, Iran. Virus stock 
was prepared by infection of confluent 
monolayer Hela cells in 75 cm2 culture 
flasks using DMEM medium with 2% FBS, 
at 37°C in 5% CO2. Virus titer was 
determined by cytopathic effect (CPE) of 
adenovirus in Helacells and was expressed 
as the 50% Tissue Culture Infective Dose 
(TCID50) per ml. 
Prior to the investigation of  
Antiadenovirus activity, the cytotoxic effect 
(CPE) of the extract was determined. 
Briefly, Helacells were seeded onto 96-well 
plates with a concentration of 10000 
cells/well with final volume of 100 µl per 
well. After incubation at 37°C with 5% 
CO2 for 24h, when the cell monolayer was 
confluent, the cell culture medium of cells 
aspirated and washed with Phosphate-
Buffered Saline(PBS). Cells were incubated 
with 100 µL/well of various concentrations 
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of ethanolic extract (in triplicates), and 
incubated at 37°C with 5% CO2 for further 
5 days. Cell viability was examined by 
ability of the cells to cleave the tetrazolium 
salt MTT [3-(4, 5-dimethylthiazol-2ol)  
2, 5 diphenyltetrazolium bromide), (Sigma, 
USA), by the mitochondrial enzyme 
succinate dehydrogenase which develops a 
formazan blue color product and the 
procedure was followed as described 
earlier
31
. Briefly, the supernatants were 
removed from the wells and 50 μL of an 
MTT (Sigma, USA) solution (1 mg/mL in 
PBS) was added to each well. The plates 
were incubated for 4 h at 37°C, and 100 μL 
of DMSO (Samchunkorea) was added to 
the wells to dissolve the MTT crystals. The 
plates were placed on a shaker for 15 min 
and the absorbance were read on an 
enzyme-linked immunosorbent assay 
(ELISA) reader (STATA FAX 2100, USA) 
at 492 nm. Data were calculated as the 
percentage of toxicity using the following 
formula: toxicity (%)= [100– (At/As) ×100] 
%, where At and As refer to the absorbance 
of the test substance and the solvent 
control, respectively.
31,36
 The 50% 
cytotoxic concentration (CC50) was defined 
as the cytotoxic concentration of the crude 
extract by regression analysis. 
Antiviral activity of the extract was 
evaluated by inhibitory activity assay using 
MTT method, as described previously.
31
 
Briefly, Non-cytotoxic concentrations of 
the extract below the CC50 value were used 
to test the ability of them to inhibit CPE of 
adenovirus in tissue culture. To confluent 
Helacell monolayer in a 96-well plate,  
100 µl (100TCID50) virus suspension was 
added and incubated at 37 °C for about one 
hour to allow virus adsorption. Thereafter, 
serial twofold dilutions prepared from non-
toxic dose of the extract was added and 
tested in triplicate. As positive control, 
cells were infected with the same 
concentration of virus but without addition 
of extract. As a negative or cell control, 
only 1% DMEM was added to the cells. 
The plates were incubated at 37 °C in a 
humidified CO2 atmosphere for 5 days. 
Cell viability was also determined 
using previously described MTT assay.
31
 
Data were calculated as the percentage of 
inhibition using the following formula: 
Antiviral activity (%)= (Atv–Acv)/  
(Acd–Acv) ×100%, where Atv, Acv, and 
Acd are the absorbance of the test 
compounds on virus infected cells, the 
absorbance of the virus control and the 
absorbance of the cell control, 
respectively.
31
 The procedure was carried 
out three times. The 50% inhibitory 
concentration (IC50) was determined from a 
curve relating inhibition to the 
concentration of the extract. Selectivity 
index (SI), as a marker of antiviral activity, 
was determined as the ratio of CC50 to IC50. 
All experiences were carried out in 
triplicate. The IC50 and CC50 values were 
calculated using dose-response analyses 
and related models with probit procedure 
using SPSS program. P<0.05 was 
considered statistically significant. 
 
RESULTS 
Total amount of phenolic and 
flavonoid compounds of Pomegranate peel 
extract was 282.9 mg/g garlic acid 
equivalent and 136.6 mg/g, respectively. 
Our results showed that the scavenging 
effect of the extract increases with the 
concentration increases. The crude extract 
had IC50 values of 7.7±1.21 μg/ml. The 
results are expressed compared with 
Butylated hydroxytoluene (BHT), a 
reference standard with IC50 of 25.41±1.89 
μg/ml (Table 1). 
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Table 1: DPPH radical-scavenging activity of the pomegranate peel extract 
Sample Concentration 
(μg/ml) 
Scavenging of DPPH radical activity 
inhibition (%) (main ± SEM) 
DPPH-radical scavenging 
activity IC50 / (μg/ml) 
Pomegranate 
peel extract 
20 91.2±0.3 7.7±1.21 
10 71.9±1 
5 44.15 
2.5 30.12 
1.25 0 
BHT 50 90.8±1.5 25.41±1.89 
40 78.3±1.2 
30 55.5±0.7 
20 40.09±1.7 
10 22±1.06 
All results are presented as mean ± standard mean error of three assays; DPPH: 1,1-Diphenyl-2-
picrylhydrazyl, BHT: Butylated hydroxytoluene. 
 
Based on MTT analysis results, The 
CC50 value of crud extract on Helacells was 
165±10.1μg/ml. The analysis showed 
significant relationship between the 
concentration of the extract and cell death 
with the more increase the extract 
concentration, the more cell death was 
shown (P<0.01). 
Treatment of the Helacells with 
different concentrations of crude extract at 
the same time of inoculation by adenovirus 
was done based on the method mentioned in 
materials and methods section. Based on the 
results, we understood that 3 μg/ml of the 
extract did not show any antiviral effect 
while the 30 μg/ml of that extract could 
inhibit the performing of cytopathic effect 
completely due to adenovirus replication in 
Hela cells. According to the model, with the 
increasing of the extract concentration, the 
percentage of inhibition of the cytopathic 
effect (CPE) was increased (P<0.05). 
Therefore, in Probit analysis, IC50 of 
pomegranate peel extract on adenovirus was 
18.6±6.7 μg/ml. The SI value of pomegranate 
peel extract was 8.9on adenovirus. 
 
DISCUSSION 
Based on MTT analysis results, The 
CC50 value of pomegranate peel extract on 
Helacells was 165±10.1 μg/ml and the IC50 
value on adenovirus was 18.6±6.7 μg/ml. 
The SI value of pomegranate peel extract on 
adenovirus was 8.9. Based on these results, 
pomegranate peel extract showed strong 
activity against adenovirus. 
Pomegranates (Punicagranatum L.) 
have been used for a long time as an 
antibacterial agent in traditional medicine. 
The bactericidal effect of pomegranates on a 
number of highly pathogenic and  
drug-resistant bacterial strains was 
investigated in different areas of the world. 
Methanol extract of its fruit, and especially 
the peel, exhibited the broadest antibacterial 
activity.
37
 The fruit of pomegranate and its 
extracts has been reported to be effective 
against influenza virus, herpes simplex 
virus, poxviruses, and human 
immunodeficiency (HIV-1) virus.
38-41 
Methanol extracts of pomegranate are 
highly rich in hydrolyzable tannins 
(punicalins and punicalagins), ellagic acid, a 
component of ellagitannins, and gallic acid, 
a component of gallotannins.
42
 Both 
antibacterial and antiviral effects of 
pomegranate most probably are associated 
with the hydrolyzable tannins and 
anthocyanins.
43
 There is one published 
report indicating out of four flavonoid 
compounds pomegranates (ellagic acid, 
caffeic acid, luteolin, and punicalagin) of 
pomegranates only punicalagin had 
inhibitory effect on influenza virus.
44
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For using in this study, the extract was 
prepared with 70% ethanol, and after drying, 
tested without further purification. It has been 
suggested that more purification of the extract 
might increase its antiviral activity. As the 
extract was not completely purified, it probably 
showed its partial antiviral activity and it 
should be possible to increase the antiviral 
activity through purification of the extract. 
 
CONCLUSION 
Our results showed that pomegranate 
(Punicagranatum L.) peel extract exhibited 
Anti-adenovirus activity, with SI value of 
8.9. This may suggest the extract as a 
potential Anti-adenovirus agent. Also this 
extract with high phytoconstituents could be 
a promising source of medicinally important 
natural compounds. 
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